MARY BLATTMAN: Open Payments
NPI 1245519628 · CARROLLTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,657 in 41 payments from 13 companies in 2025. Trend: 2023 $772 · 2024 $700 · 2025 $1,657
Food & beverage: $886Travel & lodging: $770
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 11 | $1,148 |
| ABBVIE INC. | 15 | $244 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $55 |
| Merck Sharp & Dohme LLC | 2 | $30 |
| Otsuka America Pharmaceutical, Inc. | 2 | $29 |
| Verona Pharma, Inc. | 1 | $23 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
| Vanda Pharmaceuticals Inc. | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
Products named: MINIMED 780G, VRAYLAR, CAPLYTA, REXULTI, Ohtuvayre, LEQVIO, HETLIOZ, TRELEGY ELLIPTA.
Industry payments across KY — which companies pay providers there.
